Enzo Biochem to Report Second Quarter 2022 Financial Results and Business Update on Monday, March 14th
Conference Call and Webcast Scheduled for March 14, 2022, 4:30 pm ET NEW YORK, NY, March 08, 2022 (GLOBE NEWSWIRE)...
Month: March 2022
BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
BioNTech and Regeneron plan to jointly conduct clinical trials evaluating FixVac candidate BNT116 in combination with Libtayo for the treatment...
Sanofi recognized by S&P as one of the most sustainability-committed companies
Sanofi recognized by S&P as one of the most sustainability-committed companies Paris, March 8, 2022. Sanofi was today recognized as...
Catalyst Pharmaceuticals Named Among Forbes 2022 America’s Best Small Companies
The Company Ranked 65th of More Than 1,000 Companies AssessedCORAL GABLES, Fla., March 08, 2022 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals,...
Amedisys to Present at Multiple Healthcare Conferences in March
BATON ROUGE, La., March 08, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice,...
Achilles Therapeutics to Present at the 32nd Annual Oppenheimer Healthcare Conference
LONDON, March 08, 2022 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell...
Monopar to Present at the 34th Annual Roth Conference and Maxim’s 2022 Virtual Growth Conference
WILMETTE, Ill., March 08, 2022 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing...
GelStat Provides Corporate Update on Capital Restructuring
STUART, Fla., March 08, 2022 (GLOBE NEWSWIRE) -- GelStat Corporation ("GelStat" or the "Company") (OTCPink: GSAC), a development stage company...
Frontier Medicines Announces the Appointment of Monique Bobadilla as Chief People and Culture Officer
SOUTH SAN FRANCISCO, Calif., March 08, 2022 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock...
Achieve Life Sciences Announces Participation in March Investor Conferences
SEATTLE, Wash. and VANCOUVER, British Columbia, March 08, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage...
Marrone Bio Innovations to Report Fourth Quarter and Full Year 2021 Results on Monday, March 28 at 4:30 p.m. Eastern Time
RALEIGH, N.C., March 08, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers...
VBL Therapeutics Announces Completion of Enrollment in OVAL Phase 3 Registration-Enabling Trial of Ofra-Vec in Ovarian Cancer and Unanimous Recommendation by Independent Data Safety Monitoring Committee to Continue Study as Planned
Phase 3 OVAL trial enrolled 409 patients globally at centers in the United States, Europe, Israel, and JapanTop-line data from...
X4 Pharmaceuticals to Announce Fourth Quarter 2021 Financial Results and Host a Conference Call and Webcast on March 17, 2022
BOSTON, March 08, 2022 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel...
The iQ Group Global secures worldwide license for Harvard University’s eRapid technology for at-home diagnostic testing
Affordable rapid multiplexed biomarker detection at the point-of-care for patients and practitionersSYDNEY, Australia, March 08, 2022 (GLOBE NEWSWIRE) -- Antisoma...
Ocuphire Completes Enrollment in MIRA-4 Pediatric Safety Trial Evaluating Nyxol® for Reversal of Mydriasis
With Growing Rate of Childhood Myopia, MIRA-4 Trial Supports a Potential Broader RM Label for Nyxol in Pediatric Subjects 3...
Women’s Brain Health Initiative and Brain Canada join forces to fund sex and gender considerations in brain research
Six Canadian research teams have been awarded funding for the implementation and/or continuation of sex and gender considerations in research...
Recce Pharmaceuticals Announces Safety Committee Clears Next Dose in Phase I Study of RECCE® 327
Highlights: Independent Safety Committee unanimously recommends cohort four (RECCE® 327 at 1,000mg) to commence; a 20-fold increase from cohort one...
Baudax Bio Initiates Phase IV Clinical Trial Evaluating ANJESO® in Pediatric Patients Following Surgery
MALVERN, Pa., March 08, 2022 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX) a pharmaceutical company focused on commercializing and developing...
Kala Pharmaceuticals Announces EYSUVIS® Now Covered on UnitedHealthcare Commercial and Cigna Medicare
-- Expands Commercial Coverage to 118 million lives and Medicare Coverage to 7.1 million lives -- ARLINGTON, Mass., March 08,...
Cognition Therapeutics Announces Participation in March Investment Conferences
PURCHASE, N.Y., March 08, 2022 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical stage neuroscience company developing drugs...
